(Q37405403)

20 August 2017

1 reference

title

Epigenetics of cutaneous melanoma (English)

1 reference

20 August 2017

1 reference

Willmar D Patino

1

1 reference

20 August 2017

Joseph Susa

series ordinal

2

1 reference

20 August 2017

publication date

1 January 2008

1 reference

20 August 2017

published in

Advances in dermatology

1 reference

20 August 2017

volume

24

1 reference

20 August 2017

page(s)

59-70

1 reference

An epigenetic approach to cancer etiology

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.003

Aberrant DNA methylation in cutaneous malignancies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.003

Epigenetic events in malignant melanoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.003

Transcriptional upregulation and unmethylation of the promoter region of p16 in invasive basal cell carcinoma cells and partial co-localization with the gamma 2 chain of laminin-332.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.003

Hypomethylation of DNA from benign and malignant human colon neoplasms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.003

The epigenomics of cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.003

Cancer epigenomics: DNA methylomes and histone-modification maps

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.003

Aberrant CpG-island methylation has non-random and tumour-type-specific patterns.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.003

DNA methyltransferase inhibitors for cancer therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.003

Genetic and epigenetic alterations of the APC gene in malignant melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.003

Aberrant p27Kip1 promoter methylation in malignant melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.003

Significant impact of promoter hypermethylation and the 540 C>T polymorphism of CDKN2A in cutaneous melanoma of the vertical growth phase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.003

Epigenetic inactivation of tumor suppressor genes in serum of patients with cutaneous melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.003

Profiling epigenetic inactivation of tumor suppressor genes in tumors and plasma from cutaneous melanoma patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.003

Silencing of Peroxiredoxin 2 and aberrant methylation of 33 CpG islands in putative promoter regions in human malignant melanomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.003

Promoter methylation profiling of 30 genes in human malignant melanoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.003

Silencing of the thrombomodulin gene in human malignant melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.003

ASC/TMS1, a caspase-1 activating adaptor, is downregulated by aberrant methylation in human melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.003

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.003

Exceptionally high protection of photocarcinogenesis by topical application of (--)-epigallocatechin-3-gallate in hydrophilic cream in SKH-1 hairless mouse model: relationship to inhibition of UVB-induced global DNA hypomethylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.003

p16(MTS-1/CDKN2/INK4a) in cancer progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.003

The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.003

Promoter methylation controls the expression of MAGE2, 3 and 4 genes in human cutaneous melanoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.003

Phenotypic and functional changes of human melanoma xenografts induced by DNA hypomethylation: immunotherapeutic implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.003

Smads and chromatin modulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.003

The diverse functions of histone acetyltransferase complexes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.003

Transcriptional regulation and transformation by Myc proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.003

The relation between c-myc expression and interferon sensitivity in uveal melanoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.003

Oncogenic activation of c-Myb correlates with a loss of negative regulation by TIF1beta and Ski.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.003

SKI pathways inducing progression of human melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.003

Histone demethylation mediated by the nuclear amine oxidase homolog LSD1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.003

The role of histone H3 phosphorylation (Ser10 and Ser28) in cell growth and cell transformation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.003

The Ras-MAPK signal transduction pathway, cancer and chromatin remodeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.003

Phosphorylation of histone H3: a balancing act between chromosome condensation and transcriptional activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.003

Chromatin modifier enzymes, the histone code and cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.003

DNA damage triggers nucleotide excision repair-dependent monoubiquitylation of histone H2A

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.003

The EORTC Early Clinical Trials Cooperative Group experience with 5-aza-2'-deoxycytidine (NSC 127716) in patients with colo-rectal, head and neck, renal carcinomas and malignant melanomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.003

Phase I trial of sequential low-dose 5-aza-2'-deoxycytidine plus high-dose intravenous bolus interleukin-2 in patients with melanoma or renal cell carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.003

Inactivation of the apoptosis effector Apaf-1 in malignant melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.003

Epigenetic lesions in malignant melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.003

Histone deacetylase inhibitors and malignant melanoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.003

A synthetic inhibitor of histone deacetylase, MS-27-275, with marked in vivo antitumor activity against human tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.003

Modulation of pro- and anti-apoptotic factors in human melanoma cells exposed to histone deacetylase inhibitors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.003

Melanoma cell lines are susceptible to histone deacetylase inhibitor TSA provoked cell cycle arrest and apoptosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.003

Histone deacetylase inhibitor FK228 suppresses the Ras-MAP kinase signaling pathway by upregulating Rap1 and induces apoptosis in malignant melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.003

Overexpression of histone deacetylase 1 confers resistance to sodium butyrate-mediated apoptosis in melanoma cells through a p53-mediated pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.003

Histone acetylation regulates the cell type specific CIITA promoters, MHC class II expression and antigen presentation in tumor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.003

Histone deacetylase inhibitors induce TAP, LMP, Tapasin genes and MHC class I antigen presentation by melanoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.003

Histone deacetylase inhibitors radiosensitize human melanoma cells by suppressing DNA repair activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.003

DNA methylation and diet in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.003

Cancer susceptibility: epigenetic manifestation of environmental exposures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.003

p53 mutational spectra and the role of methylated CpG sequences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.003

Photophysical properties of 5-methylcytidine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.003

Cytosine methylation determines hot spots of DNA damage in the human P53 gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.003

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.003

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2008.09.003

10.1016/J.YADR.2008.09.003

7 January 2021

Identifiers

DOI

1 reference

20 August 2017

1 reference